REFERENCES
- Sorensen J, Bengtsson A, Ahlner J. Fibromyalgia—are there different mechanisms in the processing of pain?. J Rheumatol 1997; 24: 1615–1621
- Henriksson K G. Is fibromyalgia a distinct clinical entity?. Pain mechanisms in the fibromyalgia syndrome. A myologist's view. Bailliere's Clinical Rheumatology, P Croft, A J Silman, 1999; 13: 455–461
- Alarcon G S, Bradley L. Advances in the treatment of fibromyalgia: Current status and future directions. Am J Med Sci 1998; 315(6)397–404
- Sim J S, Adams N. Physical and other non-pharmacological interventions for fibromyalgia. Bailliere's Clinical Rheumatology, P Croft. AJ Silman. 1999; 507–523, 13
- Mannerkorpi K. Assessment and treatment of patients with fibromyalgia syndrome quantative and qualitative aspects. Lund University, LundSweden 1999, Doctoral dissertation
- Lundblad I, Elert J, Gerdle B. Randomized controlled trial of physiotherapy and Feldenkrais interventions in female workers with neck-shoulder complaints. J Occupational Med 1999; 179–194
- Feldenkrais M. Awareness through movement. Harper Collins, New York 1972
- Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160–72
- Bengtsson A, Bäckman E, Lindblom B, Skogh T. Long term follow-up of fibromyalgia patients: clinical symptoms, muscular function, laboratory tests-an eight-year comparison study. J Musculoske Pain 1994; 67–80, (2)
- Mannerkorpi K, Svantesson U, Carlsson J, Ekdahl C. Tests of functional limitations and disability for patients with fibromyalgia. Scand J Rheumatol 1997; 26: 4–13
- Mengshoel A M, Komnaes H B, Forre O. The Effects of 20 weeks physical fitness training in female patients with fibromyalgia. Clin Exp Rheumatol 1992; 10: 345–9
- Burckhardt C S, Archenholtz B, Bjelle A. Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: A Swedish version of the Quality of Life Scale. Scand J Rheumatol 1992; 21: 190–5
- Hedin P J, Burckhardt C S, Engström-Laurent A. The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient. Scand J Rheumatol 1995; 24: 69–75
- Roxendal G. Body Awareness Scale with BAS-hälsa. Studentlitteratur, Lund 1993, (In Swedish)
- Elert J, Sydnerth S-B, Åbjörnsson L, Gerdle B. Aspects of criterion validity and sensitivity of the BAS-Health Scale in chronic pain patients-A pilot study of patients at a multidisciplinary pain centre. Advances in Physiotherapy 1999; 1: 83–97
- Lorig K, Chastain R L, Ung E, Stanford S, Holman H R. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989; 32: 37–44
- Lomi C, Burckhardt C, Nordholm L, Bjelle A, Ekdahl C. Evaluation of a Swedish Version of the Arthritis Self-Efficacy Scale in people with fibromyalgia. Scand J Rheumatol 1995; 24: 282–287
- Schalling D, Åsberg M, Edman G, Oreland L. Markers for vulnerability to psychopathology: Temperament traits associated with platelet MAO activity. Acta Psychiatrica Scandinavica 1987; 76: 172–182
- Gustavsson J P. Stability and validity of self-reported personality traits Contributions to the evaluation of the Karolinska Scales of Personality. Karolinska Institute. 1997, Doctoral Dissertation
- Elert J, Rantepää Dahlqvist S, Almay B, Eisemann M. Muscle endurance, muscle tension and personality traits in patients with muscle or joint pain. J Rheumatol 1993; 20: 1550–1556
- Ekselius L, Bengtsson A, von Knorring L. Personality traits as determined by means of the Karolinska Scales of Personality in patients with fibromyalgia. J of Musculoske Pain 1998; 6(2)35–49
- Hewett J E, Buckelew S P, Johnson J C, Shaw S E, Huyser B, Zheng Fu Ying. Selection of measures suitable for evaluating change in fibromyalgia clinical trials. J Rheumatol 1995; 22: 2307–2312